Lactylation in cancer biology: Unlocking new avenues for research and therapy
Cancer Communications · 2025-11 · 45 (11) · 1367-1406
DOI: 10.1002/cac2.70054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 19.08.2025. Verfasst von Xiaoyu Hou und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Obstetrics and Gynecology, Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazh…. Hauptthemen laut MEDLINE: Neoplasms, Protein Processing, Post-Translational, Lactic Acid. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, the National key research and development program, Project of the Central Government Guiding Local in Shanxi Province.
Abstract (Originalsprache)
Lactylation, a newly identified post‐translational modification, plays a multifaceted role in cancer biology by integrating epigenetic and non‐epigenetic mechanisms. This review summarizes the latest research progress on lactylation, including its functions in epigenetic regulation and its broader impact on cellular processes. Lactate, as a metabolic byproduct, not only serves as an energy source for tumor cells but also acts as a signaling molecule driving various oncogenic processes. Lactylation facilitates cancer metabolic reprogramming, enabling tumor cells to adapt to hypoxic and nutrient‐deprived microenvironments. Moreover, lactylation mediates immune suppression in the tumor microenvironment, promoting immune evasion and therapy resistance. This review further explores the clinical potential of targeting lactylation, offering new avenues for innovation in cancer research and treatment. These findings highlight the pivotal role of lactylation in cancer progression and its significant value as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Obstetrics and Gynecology, Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
- Cancer Biology Research Center (Key Laboratory of the Ministry of Education, Hubei Provincial Key Laboratory of Tumor Invasion and Metastasis), Tongji Hospital, Tongji Medical College, Huazhong University of Science and…
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
- Department of Obstetrics and Gynecology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, Shanxi, P.R. China.
ORCID-Profile: Xiaoyu Hou
Förderung
- National Natural Science Foundation of China
- the National key research and development program
- Project of the Central Government Guiding Local in Shanxi Province
- Research and Innovation Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital
Zitieren
APA
Hou, X., Hong, Z., Zeng, H., Zhang, C., Zhang, P., Ma, D., & Han, Z. (2025). Lactylation in cancer biology: Unlocking new avenues for research and therapy. Cancer Communications, 45(11), 1367-1406. https://doi.org/10.1002/cac2.70054
Vancouver
Hou X, Hong Z, Zeng H, Zhang C, Zhang P, Ma D, et al. Lactylation in cancer biology: Unlocking new avenues for research and therapy. Cancer Communications. 2025;45(11):1367-1406. doi:10.1002/cac2.70054
BibTeX
@article{Hou2025,
author = {Hou, Xiaoyu and Hong, Zhenya and Zeng, Huimin and Zhang, Changyi and Zhang, Peng and Ma, Ding and Han, Zhiqiang},
title = {Lactylation in cancer biology: Unlocking new avenues for research and therapy},
journal = {Cancer Communications},
year = {2025},
volume = {45},
number = {11},
pages = {1367--1406},
doi = {10.1002/cac2.70054}
}
EUVIMED